Category: Legislative

Legislative

Legislative

Position on Reporting Reprints and Textbooks Appears to Be Shifting

Position on Reporting Reprints and Textbooks Appears to Be Shifting

Sept. 27, 2018 – Although it was the Obama administration’s position that reprints and textbooks received by physicians were transfers of value that were fully reportable under the Sunshine Act Open Payments regulation, the Trump administration and Congress are taking another look at the matter, according to John Kamp, Washington Counsel, Coalition for Healthcare Communication. […]

Read more

Legislative

New Jersey “Gift Ban” Up for Revision

New Jersey “Gift Ban” Up for Revision

July 27, 2018 – The aggressive “gift ban” enacted by New Jersey regulators on Jan. 15 is subject to revisions under the administration of New Jersey Governor Phil Murphy, according to an article posted yesterday in Policy & Medicine, which states that a proposed rule enumerating the changes will be published on Aug. 6. Policy […]

Read more

Legislative

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

House Appropriations Bill Does Not Include Authorization of Mandatory Drug Prices in Ads

July 13, 2018 – On the “no news is good news” front, the House Appropriations Committee voted this week on next year’s funding level for the U.S. Department of Health and Human Services (HHS) without taking up an amendment to give HHS and FDA explicit authority to mandate drug list prices in consumer advertising. “What […]

Read more

Legislative

Azar Says FDA Has Authority to Require List Prices in Drug Ads

Azar Says FDA Has Authority to Require List Prices in Drug Ads

June 13, 2018 – At a Senate Committee on Health, Education, Labor & Pensions hearing on drug pricing held yesterday, Department of Health and Human Services (HHS) Secretary Alex Azar told the committee that it is his belief that “we have the authority to require list price disclosure in TV ads,” as proposed in the […]

Read more

Legislative

McCaskill Strikes Again with Transparency Bill To Expand Sunshine Provisions

McCaskill Strikes Again with Transparency Bill To Expand Sunshine Provisions

June 8, 2018 – Sen. Claire McCaskill (D-Mo.), who announced a bill in March that would amend the tax code to “deny the deduction for advertising and promotional expenses for prescription drugs,” continues to look for ways to restrict prescription drug company activities, now introducing a bill that would significantly expand reporting under the Sunshine […]

Read more

Legislative

Oregon Transparency Bill Signed into Law

Oregon Transparency Bill Signed into Law

April 2, 2018 – An Oregon transparency bill introduced in February was signed into law March 13 by Oregon Gov. Kate Brown (D), requiring drug companies not only to report drug prices to the state annually, but also to report costs associated with developing and marketing their drugs. “The Oregon bill (HB 4005) is the […]

Read more

Legislative

Oregon Transparency Bill Calls for Reporting of Marketing Costs

Oregon Transparency Bill Calls for Reporting of Marketing Costs

Feb. 5, 2018 – A bill to increase price transparency in Oregon, scheduled to be introduced Feb. 5, would require prescription drug manufacturers not only to report drug prices to the state annually, but also would require them to report costs associated with developing and marketing their drugs. If passed, Oregon House Bill 4005 would […]

Read more

Legislative

House Bill on Sharing Certain Information about Investigational Products Moves Forward

House Bill on Sharing Certain Information about Investigational Products Moves Forward

Jan. 22, 2018 – The House Energy and Commerce Subcommittee on Health held a markup Jan. 17 that advances H.R. 2026 (http://bit.ly/2G4cRM1), the “Pharmaceutical Information Exchange Act,” which will clarify how drug and medical device companies can share health care economic or scientific information about investigational drugs or devices with payers and formulary committees. “By […]

Read more

Legislative

Sen. McCaskill Files Tax Bill Amendment to Eliminate Ad Tax Deduction

Sen. McCaskill Files Tax Bill Amendment to Eliminate Ad Tax Deduction

Nov. 13, 2017 – While it seemed like the elimination of the pharma advertising tax deduction was not on the tax bill table, Sen. Claire McCaskill (D-Mo.) today filed an amendment to eliminate that tax deduction. “Although we’re taking this seriously, a Senate Democrat filing an amendment to a Republican-controlled bill is perhaps not a […]

Read more

Legislative

Elimination of Ad Tax Deduction Is Not in Tax Bill

Elimination of Ad Tax Deduction Is Not in Tax Bill

Nov. 2, 2017 – In a memo sent to Coalition for Healthcare Communication members today, CHC Executive Director John Kamp reported that the Republican tax bill just announced “DOES NOT contain a provision to reduce the immediate deductibility of marketing costs, meaning we survived the first hurdle in this tax bill. Kamp told Coalition members […]

Read more